scholarly journals Colposcopic features of cervical oncotropic papilloma-virus infection in patients with various pathology of uterine cervix

2021 ◽  
Vol 51 (4) ◽  
pp. 48-51
Author(s):  
L. A. Kolomiyets ◽  
O. N. Churuksayeva ◽  
L. N. Urazova ◽  
N. V. Sevostyanova
Keyword(s):  
Uterine Cervix ◽  
Cervical Dysplasia ◽  
Hpv Infection ◽  
Cervix Cancer ◽  
Benign Tumors ◽  
Cervical Neoplasms ◽  
Atypical Epithelium ◽  
Cytological Examination ◽  
Papilloma Virus ◽  
Uterine Cervix Cancer

In order to estimate the colposcopic manifestations of cervical oncotropic human papilloma-virus (HPV)-infection, a total of 693 patients were examimed. Among them, there were 298 patients with benign tumors pathology, 57 patients with 1-3 Grade cervical dysplasia of mucosa, 50 patients with uterine cervix cancer, 288 healthy women. All patients underwent bimanual examination, taking of cervical smears for cytological examination and uterine cervix colposcopy. Diagnosis for HPV16/18 infection was made by the method of polimerase chain reaction. А large variety in colposcopic manifestations of HPV-infection was found, namely: areas of atypical vessels, leukoplakia sites,fields of atypical epithelium, iodine-negative sites. It was related to the influence of oncogenic types of HPV infection. In these patients,fields of atypical epithelium, atypical vessels, iodinenegative areas were observed 1.2, 2.5, 10.5 times more frequently, respectively. It was found that all varieties of papillomas occurred among patients with pathology, whereas flat condylomas presenting the most difficulties of or diagnosis prevailed in patients with cervical neoplasms and uterine cervix cancer The most pronounced colposcopic evidences of uterine cervix epithelium malignancy were observed in patients with virus-positive uterine cervix cancer.

Computed tomography of iliopsoas involvement in uterine cervix cancer

1987 ◽  
Vol 23 (6) ◽  
pp. 1038
Author(s):  
J U Chung ◽  
B I Choi ◽  
S H Kim ◽  
M C Han ◽  
C W Kim
Keyword(s):  
Computed Tomography ◽  
Uterine Cervix ◽  
Cervix Cancer ◽  
Uterine Cervix Cancer

Arachidonyl ethanolamide induces apoptosis of uterine cervix cancer cells via aberrantly expressed vanilloid receptor-1

2004 ◽  
Vol 93 (1) ◽  
pp. 182-188 ◽  
Author(s):  
Emmanuel Contassot ◽  
Mirna Tenan ◽  
Valérie Schnüriger ◽  
Marie-Françoise Pelte ◽  
Pierre-Yves Dietrich
Keyword(s):  
Cancer Cells ◽  
Uterine Cervix ◽  
Vanilloid Receptor ◽  
Cervix Cancer ◽  
Uterine Cervix Cancer ◽  
Vanilloid Receptor 1

Depression before and after uterine cervix and breast cancer neoadjuvant chemotherapy

2002 ◽  
Vol 12 (6) ◽  
pp. 773-776 ◽  
Author(s):  
C. R. R. Miranda ◽  
C. N. De Resende ◽  
C. F. E. Melo ◽  
A. L. Costa ◽  
H. Friedman
Keyword(s):  
Breast Cancer ◽  
Treatment Outcome ◽  
Neoadjuvant Chemotherapy ◽  
Cancer Patients ◽  
Uterine Cervix ◽  
Cervix Cancer ◽  
Breast Cancer Patients ◽  
Uterine Cervix Cancer ◽  
End Of Treatment ◽  
Before And After

Depression in cancer patients is common and may affect treatment outcome either directly (by lowering defenses) or indirectly (by lowering compliance). Neoadjuvant chemotherapy for advanced uterine cervix or breast cancer is a strenuous undertaking and may lead to depression and impair patients' willingness to comply with the rest of the treatment (eg, surgery or radiotherapy).We compare Beck Depression Inventory (BDI) scores both before and after neoadjuvant chemotherapy in order to verify if depression influences treatment outcome. We studied 22 advanced uterine cervix and 20 breast cancer patients submitted to three courses of neoadjuvant chemotherapy. We used cisplatin and ifosfamide for cervix, and fluorouracil, adriamycin, and cyclophosphamide for breast cancer. We did not identify significant differences in the number of depressed patients, before and after treatment. Cognitive affective, somatic-performance, and total BDI scores were not significantly different from before to after chemotherapy for both breast and uterine cervix cancer. After treatment, the number of depressive breast cancer patients increased while the number of uterine cervix cancer patients decreased. This trend to depression was found more often in less responsive breast cancer patients than in the more responsive cervix cancer patients. We were not able to link depression to treatment failure or success, but patients who responded to treatment were less depressed at the end of treatment.

Sign in / Sign up

Export Citation Format

Share Document